Submission Deadline April 16, 2023
All poster presenters should send their presentation no later than April 16, 2023. No Posters will be accepted after the deadline.
All Posters will be displayed in the Poster area. The Posters can be looked up by poster number, title, category or presenting author name.
Besides being displayed onsite, all posters will be made available for viewing on the conference website for up to one month after the conference, if the presenting author so wishes.
Formats that can be used
- All submissions must be in MS-PowerPoint format.
- The PowerPoint file must have the .ppt or .pptx suffix to be accepted.
- Only one PowerPoint file may be submitted per poster.
- Posters will be viewed on 55’’ LCD screens (47.9’’ x 27’’).
- Screen ratio: 16:9. In Microsoft Office 2013 the default format is now 16:9 but if you are using older versions you must change the slide master BEFORE you create your Poster.
- Page set up: 90x120cm.
- Avoid using small images and text if possible. For images, you can use format .jpeg or .png with 72 or 96 dpi resolution and similar size.
- Landscape format.
- The electronic poster sessions will have no connection to the internet. Therefore Hyperlinks should be removed.
- Animated images, animations and animated slide transitions are not permitted for Posters and will be non-functioning.
- No audio speakers will be available, so please do not include audio in your presentation
- Maximum 1 slide can be uploaded for each Poster
- File size limit is 5 MB. You may send your file with WeTransfer through the following link: wetransfer.com to the following email address: firstname.lastname@example.org
The final poster will be subject to quality control.
IMPORTANT: Please note that WCA2023 policies do not allow displaying pharmaceutical products or company logos anywhere on your poster.
The disclosure statement submitted together with the abstract will be published online at the Meeting website, and you should include the statement in your poster.